Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
The new logo incorporates three beating hearts seamlessly & reinforces 'healthcare with a heart' into the Group's visual identity
This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
The product is expected to start contributing meaningfully to the revenue from FY25
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
To implement AI-enabled chest X-ray solution for TB & COVID-19 screening in Maharashtra through Unitaid funding
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
Subscribe To Our Newsletter & Stay Updated